Tobacco products present a deadly combination of nicotine addiction and carcinogen
exposure resulting in millions of cancer deaths per year worldwide. A plethora of smokeless …

Tobacco harm reduction remains a controversial topic in tobacco control. Tobacco harm
reduction involves providing tobacco users who are unwilling or unable to quit using …

Abstract Background In May 2018, the Secretariat for the World Health Organization
Framework Convention on Tobacco Control convened a meeting to discuss the potential for …

Combustible tobacco use has reached historic lows, demonstrating the importance of
proven strategies to reduce smoking since publication of the 1964 Surgeon General's report …

Abstract Background The US Food and Drug Administration (FDA) is considering reducing
nicotine levels in cigarettes to “minimally or non-addictive levels.” However, important …

Introduction As the science base around the potential benefits of a reduced-nicotine
standard for cigarettes grows, information on the potential effects on adolescent smokers is a …

Introduction A national nicotine reduction policy could reduce the public health toll of
smoking. However, reducing nicotine in cigarettes may lead to changes in the use of other …

There has been long-standing interest in a reduced-nicotine product standard for combusted
tobacco, which is within the regulatory purview of the Food and Drug Administration (FDA) …

Introduction A joint meeting was held by the World Health Organization (WHO) and the
Convention Secretariat of the WHO Framework Convention on Tobacco Control to examine …

Abstract The Tobacco Regulatory Science Program is a collaborative research effort
between the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) …